Red wine makes cancer drug more potent
February 15th, 2011 - 4:01 pm ICT by IANSLondon, Feb 15 (IANS) Resveratrol, a compound which gives red wine its colour, makes breast cancer drug rapamycin more potent.Lab tests found the ingredient can prevent cancer cells from developing resistance to the drug.
Resveratrol is a potent antioxidant produced by plants such as grapes, raspberries, cranberries and peanuts to fight off fungal and bacterial infections, the journal Cancer Letters reports.
Scientists have been exploring its potential in reducing the risk of heart disease, Alzheimer’s and even the ageing process, according to the Daily Mail.
Prof Charis Eng from Cleveland Clinic’s Lerner Research Institute in Ohio, said: “Rapamycin has been used in clinical trials as a cancer treatment. Unfortunately, after a while, the cancer cells develop resistance to rapamycin.
“Our findings show resveratrol seems to mitigate rapamycin-induced drug resistance in breast cancers, at least in the laboratory.”
Resveratrol is also available in supplement form. In high doses it causes side effects such as insomnia, joint pain, diarrhoea and acne.
- Red wine compound 'can give a boost to breast cancer treatment' - Feb 15, 2011
- Red wine compound can halt breast cancer - Oct 02, 2011
- New compound staves off obesity - Apr 05, 2012
- Grape compound increases beneficial fat hormone - Jan 08, 2011
- Genetic predisposition for breast, kidney cancers discovered - Dec 23, 2010
- You can spice up meals with real vitamins, nutrients - Mar 27, 2012
- Raspberry extract can beat colon cancer - Jan 18, 2011
- Analyzing family health history 'best way for disease risk assessment' - Nov 06, 2010
- Tomato plants produce unique antioxidant - Jul 24, 2011
- Natural compound prevents diabetes - Sep 04, 2011
- Silencing 'hedgehog' molecule halts cancer - Jun 06, 2011
- Red wine may protect brain against stroke damage - Apr 25, 2010
- Cheers! Drinking red wine 'can help you live longer' - Jul 31, 2010
- Cheers! Red wine can suppress inflammation in humans - Jul 30, 2010
- New genetic signatures of breast cancer drug resistance identified - Jan 11, 2011
Tags: ageing process, bacterial infections, breast cancer, breast cancer drug, breast cancers, cancer cells, cancer letters, cancer treatment, charis, cleveland clinic, daily mail, disease alzheimer, drug resistance, journal cancer, lab tests, lerner research institute, london feb, potent antioxidant, red wine, risk of heart disease